Michael G. Schlossmacher

15.9k total citations · 6 hit papers
81 papers, 11.6k citations indexed

About

Michael G. Schlossmacher is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Michael G. Schlossmacher has authored 81 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Neurology, 29 papers in Cellular and Molecular Neuroscience and 25 papers in Physiology. Recurrent topics in Michael G. Schlossmacher's work include Parkinson's Disease Mechanisms and Treatments (57 papers), Neurological disorders and treatments (25 papers) and Nuclear Receptors and Signaling (20 papers). Michael G. Schlossmacher is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (57 papers), Neurological disorders and treatments (25 papers) and Nuclear Receptors and Signaling (20 papers). Michael G. Schlossmacher collaborates with scholars based in United States, Canada and Germany. Michael G. Schlossmacher's co-authors include Dennis J. Selkoe, Beth L. Ostaszewski, Christian Haass, Albert Y. Hung, David B. Teplow, Brit Mollenhauer, Christine Klein, Dale Schenk, Joseph J. Locascio and Matthew J. LaVoie and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Michael G. Schlossmacher

78 papers receiving 11.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amyloid β-peptide is produced by cultured cells during normal metabolism

1992 1.6k citations Christian Haass, Michael G. Schlossmacher et al. profile →
Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease

2006 1.1k citations Michael G. Schlossmacher, Wei Gai et al. Journal of Biological Chemistry profile →
Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease

2001 842 citations Hideki Shimura, Michael G. Schlossmacher et al. profile →
Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease

2006 592 citations Omar M. A. El‐Agnaf, Michael G. Schlossmacher et al. profile →
Dopamine covalently modifies and functionally inactivates parkin

2005 580 citations Matthew J. LaVoie, Beth L. Ostaszewski et al. profile →
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

2011 489 citations Brit Mollenhauer, Walter Schulz‐Schaeffer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael G. Schlossmacher United States	47	6.9k	5.0k	3.7k	3.3k	1.8k	81	11.6k
Pamela J. McLean United States	55	6.4k 0.9×	4.3k 0.9×	4.3k 1.2×	3.7k 1.1×	1.7k 1.0×	112	12.0k
Omar M. A. El‐Agnaf Qatar	54	6.6k 1.0×	4.7k 0.9×	2.9k 0.8×	2.6k 0.8×	1.7k 0.9×	148	10.8k
Shigeo Murayama Japan	61	6.0k 0.9×	5.8k 1.1×	5.4k 1.5×	2.9k 0.9×	2.8k 1.6×	409	14.2k
Tiago F. Outeiro Germany	71	8.3k 1.2×	5.3k 1.1×	6.4k 1.8×	4.6k 1.4×	2.4k 1.3×	341	16.9k
Mel Β. Feany United States	54	5.2k 0.8×	4.8k 1.0×	5.4k 1.5×	4.8k 1.4×	1.8k 1.0×	106	13.4k
Huaibin Cai United States	47	3.2k 0.5×	3.4k 0.7×	3.7k 1.0×	2.6k 0.8×	1.5k 0.8×	117	8.8k
Makoto Hashimoto Japan	49	6.1k 0.9×	3.6k 0.7×	2.5k 0.7×	3.8k 1.1×	2.2k 1.3×	126	9.9k
Jie Shen United States	50	6.8k 1.0×	4.8k 0.9×	6.5k 1.8×	5.0k 1.5×	1.9k 1.1×	112	14.7k
Mark S. Forman United States	47	4.7k 0.7×	4.0k 0.8×	2.9k 0.8×	1.5k 0.4×	1.7k 0.9×	82	9.1k
Robert L. Nussbaum United States	39	9.6k 1.4×	4.2k 0.8×	4.4k 1.2×	5.2k 1.6×	2.3k 1.3×	54	14.1k

Countries citing papers authored by Michael G. Schlossmacher

Since Specialization

Citations

This map shows the geographic impact of Michael G. Schlossmacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Schlossmacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Schlossmacher more than expected).

Fields of papers citing papers by Michael G. Schlossmacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Schlossmacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Schlossmacher. The network helps show where Michael G. Schlossmacher may publish in the future.

Co-authorship network of co-authors of Michael G. Schlossmacher

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Schlossmacher. A scholar is included among the top collaborators of Michael G. Schlossmacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Schlossmacher. Michael G. Schlossmacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ortiz, Z, et al.. (2025). Race and ethnicity matter! Moving Parkinson’s risk research towards diversity and inclusiveness. npj Parkinson s Disease. 11(1). 45–45.

Aylsworth, Amy, Allison Macdonald, William A. Staines, et al.. (2024). Unraveling the assembloid: Real-time monitoring of dopaminergic neurites in an inter-organoid pathway connecting midbrain and striatal regions. Materials Today Bio. 25. 100992–100992. 6 indexed citations

Koch, Marcus, Lorraine V. Kalia, Justyna R. Sarna, et al.. (2024). Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease. Neurology. 104(1). e210079–e210079.

Jensen, Poul Henning, Michael G. Schlossmacher, & Leonidas Stefanis. (2023). Who Ever Said It Would Be Easy? Reflecting on Two Clinical Trials Targeting α‐Synuclein. Movement Disorders. 38(3). 378–384. 19 indexed citations

Outeiro, Tiago F., Roy N. Alcalay, Angelo Antonini, et al.. (2023). Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson's Disease”. Movement Disorders. 38(7). 1127–1142. 20 indexed citations

Surendra, Anuradha, Hongbin Xu, Irina Alecu, et al.. (2021). BATL: Bayesian annotations for targeted lipidomics. Bioinformatics. 38(6). 1593–1599. 4 indexed citations

Oliveira, Luís M. A., Thomas Gasser, Robert H. Edwards, et al.. (2021). Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. npj Parkinson s Disease. 7(1). 65–65. 96 indexed citations

Wilson, Mark A., et al.. (2021). Neurodegeneration: Impact of S-nitrosylated Parkin, DJ-1 and PINK1 on the pathogenesis of Parkinson's disease. Archives of Biochemistry and Biophysics. 704. 108869–108869. 19 indexed citations

Kruse, Niels, Michael G. Schlossmacher, Walter Schulz‐Schaeffer, et al.. (2016). A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid. PLoS ONE. 11(4). e0153564–e0153564. 5 indexed citations

10.

Ekholm‐Reed, Susanna, Matthew S. Goldberg, Michael G. Schlossmacher, & Steven I. Reed. (2013). Parkin-Dependent Degradation of the F-Box Protein Fbw7β Promotes Neuronal Survival in Response to Oxidative Stress by Stabilizing Mcl-1. Molecular and Cellular Biology. 33(18). 3627–3643. 60 indexed citations

11.

Rousseaux, Maxime W.C., Paul C. Marcogliese, Dianbo Qu, et al.. (2012). Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease. Proceedings of the National Academy of Sciences. 109(39). 15918–15923. 64 indexed citations

12.

Cullen, Valerie, S. Pablo Sardi, Juliana Ng, et al.. (2011). Acid β‐glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α‐synuclein processing. Annals of Neurology. 69(6). 940–953. 253 indexed citations

13.

Klein, Christine, Dimitri Krainc, Michael G. Schlossmacher, & Anthony E. Lang. (2011). Translational Research in Neurology and Neuroscience 2011. Archives of Neurology. 68(6). 709–16. 9 indexed citations

14.

Cullen, Valerie, Maria Lindfors, Juliana Ng, et al.. (2009). Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Molecular Brain. 2(1). 5–5. 236 indexed citations

15.

LaVoie, Matthew J., Giuseppe P. Cortese, Beth L. Ostaszewski, & Michael G. Schlossmacher. (2007). The effects of oxidative stress on parkin and other E3 ligases. Journal of Neurochemistry. 103(6). 2354–2368. 65 indexed citations

16.

Klein, Christine & Michael G. Schlossmacher. (2006). The genetics of Parkinson disease: implications for neurological care. Nature Clinical Practice Neurology. 2(3). 136–146. 125 indexed citations

17.

Bandopadhyay, Rina, Ann E. Kingsbury, Miratul M. K. Muqit, et al.. (2005). Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition. Neurobiology of Disease. 20(2). 401–411. 34 indexed citations

18.

Schlossmacher, Michael G., Matthew P. Frosch, Wei Gai, et al.. (2002). Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies. American Journal Of Pathology. 160(5). 1655–1667. 255 indexed citations

19.

Schlossmacher, Michael G.. (1998). The life of Eugene Braunwald: a remarkable journey that began in Vienna.. PubMed. 110(1). 27–34. 2 indexed citations

20.

Haass, Christian, Albert Y. Hung, Michael G. Schlossmacher, David B. Teplow, & Dennis J. Selkoe. (1993). beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms.. Journal of Biological Chemistry. 268(5). 3021–3024. 377 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact